Appropriate use of morphological imaging for assessing treatment response and disease progression of neuroendocrine tumors

Baseline tumor growth rate highlights the heterogeneity of well differentiated gastroenteropancreatic neuroendocrine tumors and predicts for increases in Ki67 index over time

(2023) Stephanie J. Wang et al.   JOURNAL OF NEUROENDOCRINOLOGY

Proposal of early CT morphological criteria for response of liver metastases to systemic treatments in gastroenteropancreatic neuroendocrine tumors: Alternatives to RECIST

(2023) Louis de Mestier et al.   JOURNAL OF NEUROENDOCRINOLOGY

The use of deep learning models to predict progression-free survival in patients with neuroendocrine tumors

(2023) Marianne Pavel et al.   Future Oncology

Conventional Transarterial Chemo embolization Using Streptozocin in Patients with Unresectable Neuroendocrine Liver Metastases

(2023) Audrey Fohlen et al.   Cancers

Defining disease status in gastroenteropancreatic neuroendocrine tumors: Choi-criteria or RECIST?

(2022) M. J. C. van Treijen et al.   Abdominal Radiology

Comparison of Choi, RECIST and Somatostatin Receptor PET/CT Based Criteria for the Evaluation of Response and Response Prediction to PRRT

(2022) Kevin Zwirtz et al.   Pharmaceutics

Criteria for the translation of radiomics into clinically useful tests

(2022) Erich P. Huang et al.   Nature Reviews Clinical Oncology

Tumor growth rate in pancreatic neuroendocrine tumor patients undergoing PRRT with 177Lu-DOTATATE

(2021) Olof Joakim Pettersson et al.   Endocrine Connections

Radiomics-Based Texture Analysis of 68Ga-DOTATATE Positron Emission Tomography and Computed Tomography Images as a Prognostic Biomarker in Adults With Neuroendocrine Cancers Treated With 177Lu-DOTATATE

(2021) Charlotte Atkinson et al.   Frontiers in Oncology

Long Term Efficacy and Assessment of Tumor Response of Transarterial Chemoembolization in Neuroendocrine Liver Metastases: A 15-Year Monocentric Experience

(2021) Caroline Touloupas et al.   Cancers

Digestive Neuroendocrine Neoplasms (NEN): French Intergroup clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, GTE, RENATEN, TENPATH, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR)

(2020) Louis de Mestier et al.   DIGESTIVE AND LIVER DISEASE

Tumour Growth Rate to predict the outcome of patients with Neuroendocrine Tumours: Performance and sources of variability

(2020) Clarisse Dromain et al.   NEUROENDOCRINOLOGY

Three-Dimensional Neural Network to Automatically Assess Liver Tumor Burden Change on Consecutive Liver MRIs

(2020) Alexander Goehler et al.   Journal of the American College of Radiology

Morphological imaging and CT histogram analysis to differentiate pancreatic neuroendocrine tumor grade 3 from neuroendocrine carcinoma

(2020) A. Azoulay et al.   Diagnostic and Interventional Imaging

Tumor growth rate as a metric of progression, response, and prognosis in pancreatic and intestinal neuroendocrine tumors

(2019) Clarisse Dromain et al.   BMC CANCER

Outcomes After Transarterial Embolization of Neuroendocrine Tumor Liver Metastases Using Spherical Particles of Different Sizes

(2019) Rebecca Zener et al.   CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY

Value of Tumor Growth Rate (TGR) as an Early Biomarker Predictor of Patients’ Outcome in Neuroendocrine Tumors (NET)—The GREPONET Study

(2019) Angela Lamarca et al.   ONCOLOGIST

Prognostic value of baseline volumetric multiparametric MR imaging in neuroendocrine liver metastases treated with transarterial chemoembolization

(2019) Yan Luo et al.   EUROPEAN RADIOLOGY

Semi-quantitative visual assessment of hepatic tumor burden can reliably predict survival in neuroendocrine liver metastases treated with transarterial chemoembolization

(2019) Yan Luo et al.   EUROPEAN RADIOLOGY

Validation of A Method to Compensate Multicenter Effects Affecting CT Radiomics

(2019) Fanny Orlhac et al.   RADIOLOGY

Tumor Growth Rate as a Validated Early Radiological Biomarker Able to Reflect Treatment-Induced Changes in Neuroendocrine Tumors: The GREPONET-2 Study

(2019) Angela Lamarca et al.   CLINICAL CANCER RESEARCH

Prediction of Pancreatic Neuroendocrine Tumor Grade Based on CT Features and Texture Analysis

(2018) Rodrigo Canellas et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

Radiomics: the bridge between medical imaging and personalized medicine

(2017) Philippe Lambin et al.   Nature Reviews Clinical Oncology

Imaging Biomarkers of Tumor Response in Neuroendocrine Liver Metastases Treated with Transarterial Chemoembolization: Can Enhancing Tumor Burden of the Whole Liver Help Predict Patient Survival?

(2017) Sonia Sahu et al.   RADIOLOGY

Observer variability in RECIST-based tumour burden measurements: a meta-analysis

(2016) Soon Ho Yoon et al.   EUROPEAN JOURNAL OF CANCER

Correlation of tumor response on computed tomography with pathological necrosis in hepatocellular carcinoma treated by chemoembolization before liver transplantation

(2016) Marco Dioguardi Burgio et al.   LIVER TRANSPLANTATION

Comparison of Existing Response Criteria in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization Using a 3D Quantitative Approach

(2016) Vania Tacher et al.   RADIOLOGY

Radiomics: Images Are More than Pictures, They Are Data

(2016) Robert J. Gillies et al.   RADIOLOGY

The Potential of Radiomic-Based Phenotyping in Precision Medicine

(2016) Hugo J. W. L. Aerts   JAMA Oncology

External validation of a prognostic CT-based radiomic signature in oropharyngeal squamous cell carcinoma

(2015) Ralph T. H. Leijenaar et al.   ACTA ONCOLOGICA

Early survival prediction after intra-arterial therapies: a 3D quantitative MRI assessment of tumour response after TACE or radioembolization of colorectal cancer metastases to the liver

(2015) Julius Chapiro et al.   EUROPEAN RADIOLOGY

Identifying Staging Markers for Hepatocellular Carcinoma before Transarterial Chemoembolization: Comparison of Three-dimensional Quantitative versus Non–three-dimensional Imaging Markers

(2015) Julius Chapiro et al.   RADIOLOGY

Predictive Value of Optimal Morphologic Response to First-Line Chemotherapy in Patients with Colorectal Liver Metastases

(2014) Hiroki Yoshita et al.   DIGESTION

Optimal Measurement Modality and Method for Evaluation of Responses to Transarterial Chemoembolization of Hepatocellular Carcinoma Based on Enhancement Criteria

(2013) Ju Hyun Shim et al.   JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY

Optimal Morphologic Response to Preoperative Chemotherapy: An Alternate Outcome End Point Before Resection of Hepatic Colorectal Metastases

(2012) Junichi Shindoh et al.   JOURNAL OF CLINICAL ONCOLOGY

Quantitative and Volumetric European Association for the Study of the Liver and Response Evaluation Criteria in Solid Tumors Measurements: Feasibility of a Semiautomated Software Method to Assess Tumor Response after Transcatheter Arterial Chemoembolization

(2012) MingDe Lin et al.   JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY

Imaging predictors of the response to transarterial chemoembolization in patients with hepatocellular carcinoma: A radiological-pathological correlation

(2012) Sharon W. Kwan et al.   LIVER TRANSPLANTATION

Intrahepatic Cholangiocarcinoma Treated with Local-Regional Therapy: Quantitative Volumetric Apparent Diffusion Coefficient Maps for Assessment of Tumor Response

(2012) Vivek Gowdra Halappa et al.   RADIOLOGY

Islet Cell Liver Metastases: Assessment of Volumetric Early Response with Functional MR Imaging after Transarterial Chemoembolization

(2012) Zhen Li et al.   RADIOLOGY

Neuroendocrine Liver Metastasis Treated by Using Intraarterial Therapy: Volumetric Functional Imaging Biomarkers of Early Tumor Response and Survival

(2012) Vivek Gowdra Halappa et al.   RADIOLOGY

Imaging response in neuroendocrine tumors treated with targeted therapies: the experience of sunitinib

(2012) Sandrine Faivre et al.   Targeted Oncology

Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study

(2011) Marianne E Pavel et al.   LANCET

Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors

(2011) Eric Raymond et al.   NEW ENGLAND JOURNAL OF MEDICINE

Everolimus for Advanced Pancreatic Neuroendocrine Tumors

(2011) James C. Yao et al.   NEW ENGLAND JOURNAL OF MEDICINE

Which Response Criteria Best Help Predict Survival of Patients with Hepatocellular Carcinoma Following Chemoembolization? A Validation Study of Old and New Models

(2011) Ju Hyun Shim et al.   RADIOLOGY

Intra-abdominal fibrosis in a recent cohort of patients with neuroendocrine ('carcinoid') tumours of the small bowel

(2010) M.R. Druce et al.   QJM-AN INTERNATIONAL JOURNAL OF MEDICINE

Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma

(2010) Riccardo Lencioni et al.   SEMINARS IN LIVER DISEASE

Treatment response classification of liver metastatic disease evaluated on imaging. Are RECIST unidimensional measurements accurate?

(2009) Michael Mantatzis et al.   EUROPEAN RADIOLOGY

Association of Computed Tomography Morphologic Criteria With Pathologic Response and Survival in Patients Treated With Bevacizumab for Colorectal Liver Metastases

(2009) Yun Shin Chun   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Evaluating Variability in Tumor Measurements from Same-day Repeat CT Scans of Patients with Non–Small Cell Lung Cancer

(2009) Binsheng Zhao et al.   RADIOLOGY

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER